In contrast, lower levels of ZEB2 (another EMT marker [30]) were detected in the M13SV1-EGFP-Neo cells compared to the HS578T-Hyg breast cancer cells (Fig. 7). This evidence concerns the gene ZEB2 and breast carcinoma.